Who owns Ambrolytin?
Ambrolytin is owned by Sopharma (Bulgaria, BSE Sofia: SFA).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Sopharma Group consolidated management report for the first half of 2026, Sopharma AD, 30 June 2026. Last checked .
Key facts
- Current owner
- Sopharma AD reported
- Owner HQ
- 🇧🇬 Bulgaria, Sofia
- Origin
- 🇧🇬 Bulgaria
- Category
- Consumer health › Over-the-counter medicine › Cold
- Parent ticker
- BSE Sofia: SFA WSE: SPH
- Last verified
- · 1 sources
About Ambrolytin
Ambrolytin is Sopharma's ambroxol syrup, sold in Bulgaria at 30 mg per 5 ml, and its Bulgarian marketing authorisation was renewed in the first half of 2026 as one of nineteen the group renewed in the period. Sopharma makes liquid dosage forms at its plants in Vrabevo, Sandanski and Veliko Tarnovo, with capacity for about seventeen million packs a year.
Ownership timeline of Ambrolytin
Where Ambrolytin sits in Sopharma
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Sopharma ownership tree →
See the full Sopharma brand portfolio (6) →
Other brands owned by Sopharma
Sopharma controls 6 brands on Brandtree, 6 of them in consumer health.
Also in consumer health
Other brands in cold, and who owns them
The 36 brands in cold on Brandtree belong to 21 owners. The largest is Krka, with 5; Sopharma has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Herbion | Krka | 🇸🇮 Slovenia |
| Breathe Right | Prestige Consumer Healthcare | 🇺🇸 United States |
| Lemsip | Reckitt | 🇬🇧 United Kingdom |
| Covonia | STADA | 🇩🇪 Germany |
| Dimestil | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| HealthCareAisle | Dr. Reddy's | 🇮🇳 India |
| Tukol | Genomma Lab | 🇲🇽 Mexico |
| Benadryl | Kenvue | 🇺🇸 United States |
About the owner: Sopharma
Sopharma is a publicly listed company headquartered in Sofia, Bulgaria, founded in 1933. Brandtree records 6 brands under its control, and it is listed as BSE Sofia: SFA and WSE: SPH.
Sopharma is the largest Bulgarian pharmaceutical company, a producer, exporter and domestic distributor of prescription medicines, generics, herbal-based substances, food supplements, cosmetics and medical devices. It was established in 1933, when the Bulgarian Pharmacists' Cooperative Society built the first laboratory for manufacturing medicines in the country on the edge of Sofia, and it became a private company in 2000. The group manufactures at twenty specialised facilities across seven sites in Bulgaria, Serbia and Ukraine, and distributes through Sopharma Trading, which it owns 87.32 per cent of, and through subsidiaries in Russia, Ukraine, Kazakhstan, Poland and Belarus.
🇧🇬 Ambrolytin and other Bulgarian brands
Brandtree records a controlling owner for 20 brands that began in Bulgaria. 13 of them (65%) are now controlled by a company headquartered in another country; Ambrolytin is not one of them.
- A1 Bulgaria — América Móvil 🇲🇽
- Angel's Estate — Maspex 🇵🇱
- Bulgaria Air — Bulgarian Airways Group 🇧🇬
- DSK Bank — OTP Bank 🇭🇺
- Devin — Spadel 🇧🇪
- Gorna Bania — Multi Group 🇦🇲
Frequently asked questions
Who is the parent company of Ambrolytin?
The parent company of Ambrolytin is Sopharma, a publicly listed company headquartered in Bulgaria.
Is Ambrolytin Bulgarian?
Yes. Ambrolytin originated in Bulgaria and its owner, Sopharma, is also headquartered in Bulgaria.
Is Ambrolytin still owned by Sopharma?
Yes. As of 20 September 2026, Ambrolytin is still owned by Sopharma. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Sopharma Group consolidated management report for the first half of 2026 — Sopharma AD, Stock exchange filing, published 30 June 2026; retrieved 20 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.